Home | All results_reference

[RDF data]
Results Reference #1125

Resource URI: http://static.linkedct.org/resource/results_reference/1125
linkedct:citation Marachelian A, Kang MH, Hwang K, et al.: Phase I study of fenretinide (4-HPR) oral powder in patients with recurrent or resistant neuroblastoma: New Approaches to Neuroblastoma Therapy (NANT) Consortium trial. [Abstract] J Clin Oncol 27 (Suppl 15): A-10009, 2009.
rdfs:label Results Reference #1125
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00295919>
linkedct:results_reference_id 1125 (xsd:int)
rdf:type linkedct:results_reference